High-grade serous tubo-ovarian carcinoma presenting as paraneoplastic cerebellar degeneration

被引：0
|
作者：
Butt, E. [1 ]
Chadda, K. R. [1 ,2 ]
Tadross, J. A. [3 ]
Latimer, J. [4 ]
机构：
[1] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge, England
[2] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England
[3] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, MRC,Metab Dis Unit,Metab Res Labs,Wellcome Trust, Cambridge, England
[4] Addenbrookes Hosp, Div Gynaecol Oncol, Dept Gynaecol, Cambridge, England
来源：
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2019年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
1362
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [41] BRCA1 and MAD2 Are Coexpressed and Are Prognostic Indicators in Tubo-ovarian High-Grade Serous Carcinoma
    Byrne, Tara
    Nelson, Laura
    Beirne, James P.
    Sharpe, Daniel
    Quinn, Jennifer E.
    McCluggage, W. Glenn
    Robson, Tracy
    Furlong, Fiona
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (03) : 472 - 478
  • [42] Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma
    Coghlan, Edwina
    Meniawy, Tarek M.
    Munro, Aime
    Bulsara, Max
    Stewart, Colin J. R.
    Tan, Adeline
    Koay, M. H. Eleanor
    MaGee, Daniel
    Codde, Jim
    Tan, Jason
    Salfinger, Stuart G.
    Mohan, Ganendra R.
    Leung, Yee
    Nichols, Cassandra B.
    Cohen, Paul A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (04) : 708 - 713
  • [43] PARP Inhibitors Differentially Regulate Immune Responses in Distinct Genetic Backgrounds of High-Grade Serous Tubo-Ovarian Carcinoma
    Pereira, Luiza Doro
    Wielgos-Bonvallet, Monica
    Misirlioglu, Selim
    Khodadai-Jamayran, Alireza
    Jelinic, Petar
    Levine, Douglas A.
    CANCER RESEARCH COMMUNICATIONS, 2025, 5 (02): : 339 - 348
  • [44] CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study
    Kang, Eun-Young
    Weir, Ashley
    Meagher, Nicola S.
    Farrington, Kyo
    Nelson, Gregg S.
    Ghatage, Prafull
    Lee, Cheng-Han
    Riggan, Marjorie J.
    Bolithon, Adelyn
    Popovic, Gordana
    Leung, Betty
    Tang, Katrina
    Lambie, Neil
    Millstein, Joshua
    Alsop, Jennifer
    Anglesio, Michael S.
    Ataseven, Beyhan
    Barlow, Ellen
    Beckmann, Matthias W.
    Berger, Jessica
    Bisinotto, Christiani
    Boesmueller, Hans
    Boros, Jessica
    Brand, Alison H.
    Brooks-Wilson, Angela
    Brucker, Sara Y.
    Carney, Michael E.
    Casablanca, Yovanni
    Cazorla-Jimenez, Alicia
    Cohen, Paul A.
    Conrads, Thomas P.
    Cook, Linda S.
    Coulson, Penny
    Courtney-Brooks, Madeleine
    Cramer, Daniel W.
    Crowe, Philip
    Cunningham, Julie M.
    Cybulski, Cezary
    Darcy, Kathleen M.
    El-Bahrawy, Mona A.
    Elishaev, Esther
    Erber, Ramona
    Farrell, Rhonda
    Fereday, Sian
    Fischer, Anna
    Garcia, Maria J.
    Gayther, Simon A.
    Gentry-Maharaj, Aleksandra
    Gilks, C. Blake
    Grube, Marcel
    CANCER, 2023, 129 (05) : 697 - 713
  • [45] High-Grade Ovarian Serous Carcinoma Presenting as Androgenetic Alopecia
    Eversman, Anna
    Tracey, Elisabeth
    Warren, Christine B.
    CUTIS, 2020, 106 (06): : E12 - E14
  • [46] HER2 Protein Overexpression and Gene Amplification in Tubo-Ovarian High-grade Serous Carcinomas
    Ersoy, Esma
    Cao, Qing Jackie
    Otis, Christopher N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2022, 41 (04) : 313 - 319
  • [47] INTRAOPERATIVE MOLECULAR ANALYSIS DURING INTERVAL CYTOREDUCTION OF HIGH-GRADE SEROUS TUBO-OVARIAN CARCINOMA TO CONFIRM NECESSITY FOR VISCERAL RESECTION
    Beirne, J. P.
    Laura, F.
    McArt, D.
    Harley, I.
    McCluggage, W. G.
    Mullan, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A439 - A439
  • [48] Inter-Observer Agreement in Assessment of Response to Neo-Adjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma
    Singh, Naveena
    Said, Ian
    Faruqi, Asma Z.
    Leen, Sarah L.
    Trevisan, Giorgia
    Hirschowitz, Lynn
    Ganesan, Raji
    Vella, Jo
    McCluggage, Glenn
    Gilks, Blake
    Boehm, Steffen
    MODERN PATHOLOGY, 2016, 29 : 309A - 310A
  • [49] Inter-Observer Agreement in Assessment of Response to Neo-Adjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma
    Singh, Naveena
    Said, Ian
    Faruqi, Asma Z.
    Leen, Sarah L.
    Trevisan, Giorgia
    Hirschowitz, Lynn
    Ganesan, Raji
    Vella, Jo
    McCluggage, Glenn
    Gilks, Blake
    Boehm, Steffen
    LABORATORY INVESTIGATION, 2016, 96 : 309A - 310A
  • [50] MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma
    Kang, Eun Young
    Millstein, Joshua
    Popovic, Gordana
    Meagher, Nicola S.
    Bolithon, Adelyn
    Talhouk, Aline
    Chiu, Derek S.
    Anglesio, Michael S.
    Leung, Betty
    Tang, Katrina
    Lambie, Neil
    Pavanello, Marina
    Da-Anoy, Annalyn
    Lambrechts, Diether
    Loverix, Liselore
    Olbrecht, Siel
    Bisinotto, Christiani
    Garcia-Donas, Jesus
    Ruiz-Llorente, Sergio
    Yague-Fernandez, Monica
    Edwards, Robert P.
    Elishaev, Esther
    Olawaiye, Alexander
    Taylor, Sarah
    Ataseven, Beyhan
    du Bois, Andreas
    Harter, Philipp
    Lester, Jenny
    Hogdall, Claus K.
    Armasu, Sebastian M.
    Huang, Yajue
    Vierkant, Robert A.
    Wang, Chen
    Winham, Stacey J.
    Heublein, Sabine
    Kommoss, Felix K. F.
    Cramer, Daniel W.
    Sasamoto, Naoko
    Van-Wagensveld, Lilian
    Lycke, Maria
    Mateoiu, Constantina
    Joseph, Janine
    Pike, Malcolm C.
    Odunsi, Kunle
    Tseng, Chiu-Chen
    Pearce, Celeste L.
    Bilic, Sanela
    Conrads, Thomas P.
    Hartmann, Arndt
    Hein, Alexander
    VIRCHOWS ARCHIV, 2022, 480 (04) : 855 - 871
12345